Prokinetic Agents
Gastrointestinal (GI) prokinetic agents are drugs that increase GI motility and promote the movement of contents in the GI tract by amplifying and controlling the contraction of GI smooth muscle. Currently used prokinetics increase GI motility by acting as a dopamine D2 receptor antagonist (e.g., me...
Saved in:
Main Authors: | Hyo Yeop Song (Author), Sung Won Jung (Author), Yong Sung Kim (Author) |
---|---|
Format: | Book |
Published: |
Yong Chan Lee,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
by: Kazumi Inokuchi, et al.
Published: (2021) -
Metoclopramide as a prokinetic agent for diabetic gastroparesis: revisiting the risk of Parkinsonism
by: Chien-Hsu Lai, et al.
Published: (2019) -
Efficacy of prokinetic agents in diabetic gastroparesis comparing symptomatology and scintigraphy - An open-label trial
by: Ravi Kant, et al.
Published: (2023) -
Efficacy and Safety of Mecobalamin Combined with Prokinetic Agents in the Treatment of Diabetic Gastroparesis: A Meta-Analysis
by: Jia Yao, et al.
Published: (2021) -
New Developments in Prokinetic Therapy for Gastric Motility Disorders
by: Michael Camilleri, et al.
Published: (2021)